Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Biomea FusionBMEA -1.74%31 EV-to-OCF is -1.88 as of Aug. 26, 2026. GuruFocus rates BMEA with a GF Score™ of 31/100. The stock has 1 warning sign investors should review. Among 1,409 Biotechnology companies, Biomea Fusion ranks worse than 59.76% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Biomea Fusion's Enterprise Value is $88.91 Mil.
Biomea Fusion's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was $-47.19 Mil. Therefore, Biomea Fusion's EV-to-OCF for today is -1.88.
The historical rank and industry rank for Biomea Fusion's EV-to-OCF or its related term are showing as below:
BMEA'
s EV-to-OCF Range Over the Past 10 Years
Min: -1.94 Med: 0 Max: -1.83
Current: -1.88
During the past 7 years, the highest EV-to-OCF of Biomea Fusion was -1.83. The lowest was -1.94. And the median was .
BMEA's EV-to-OCF is ranked worse than 59.76% of 1409
companies
in the Biotechnology industry
Industry Median: -3.71
vs BMEA: -1.88
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Biomea Fusion's PE Ratio (TTM) for today is calculated as:
Biomea Fusion's share price for today is $1.695.
Biomea Fusion's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.290.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Biomea Fusion EV-to-OCF Related Terms
Biomea Fusion EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Biomea Fusion's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Biomea Fusion's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biomea Fusion EV-to-OCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Biomea Fusion's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Biomea Fusion's EV-to-OCF falls into.
Biomea Fusion's current Enterprise Value is $88.91 Mil.
Biomea Fusion's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-47.19 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biomea Fusion (BMEA) has a EV-to-OCF of -1.88 as of Aug. 26, 2026. According to the industry distribution chart, Biomea Fusion ranks #842 out of 1409 companies in the Biotechnology industry, placing it in the top 59.8%.
Is Biomea Fusion's EV-to-OCF too high?
Biomea Fusion's current EV-to-OCF is -1.88. Based on the distribution chart, Biomea Fusion ranks #842 out of 1409 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Biomea Fusion has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Biomea Fusion's EV-to-OCF compare to NTHI and PTHS?
According to the Biotechnology industry distribution chart, Biomea Fusion ranks #842 out of 1409 companies for EV-to-OCF. This places Biomea Fusion in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Biotechnology company?
A good EV-to-OCF depends on the Biotechnology industry context. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. Biomea Fusion's current EV-to-OCF is -1.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biomea Fusion stock overvalued right now?
Biomea Fusion (BMEA) has a current EV-to-OCF of -1.88. The current EV-to-OCF is -1.88. Biomea Fusion's overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Biomea Fusion (BMEA), the current EV-to-OCF is -1.88 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Biomea Fusion Inc is a a clinical stage diabetes and obesity medicines company focused on the discovery and development of oral, small molecule drugs to treat and improve the lives of patients with diabetes, obesity, and other metabolic diseases. It operate as an organization centered on two of its core drug candidate development programs: (i) icovamenib, its clinical program's drug candidate, currently being developed as an orally bioavailable, and selective, covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity, and (ii) BMF-650, its investigational, next-generation oral glucagon-like peptide-1 GLP-1 receptor agonist in development for the treatment of obesity.
31GF Score
Get the complete analysis for BMEA
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BMEA has been successfully added to your 
